| MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response M Fabbri, A Paone, F Calore, R Galli, E Gaudio, R Santhanam, F Lovat, ... Proceedings of the National Academy of Sciences 109 (31), E2110-E2116, 2012 | 1668 | 2012 |
| Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib JA Woyach, RR Furman, TM Liu, HG Ozer, M Zapatka, AS Ruppert, L Xue, ... New England Journal of Medicine 370 (24), 2286-2294, 2014 | 1360 | 2014 |
| Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL JA Woyach, AS Ruppert, NA Heerema, W Zhao, AM Booth, W Ding, ... New England Journal of Medicine 379 (26), 2517-2528, 2018 | 971 | 2018 |
| JNK3 perpetuates metabolic stress induced by Aβ peptides SO Yoon, DJ Park, JC Ryu, HG Ozer, C Tep, YJ Shin, TH Lim, L Pastorino, ... Neuron 75 (5), 824-837, 2012 | 242 | 2012 |
| Role of ChIP-seq in the discovery of transcription factor binding sites, differential gene regulation mechanism, epigenetic marks and beyond R Mundade, HG Ozer, H Wei, L Prabhu, T Lu Cell Cycle 13 (18), 2847-2852, 2014 | 188 | 2014 |
| Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling YY Yeh, HG Ozer, AM Lehman, K Maddocks, L Yu, AJ Johnson, JC Byrd Blood, The Journal of the American Society of Hematology 125 (21), 3297-3305, 2015 | 174 | 2015 |
| Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer H Alder, C Taccioli, H Chen, Y Jiang, KJ Smalley, P Fadda, HG Ozer, ... Carcinogenesis 33 (9), 1736-1744, 2012 | 138 | 2012 |
| BRD4 profiling identifies critical chronic lymphocytic leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor HG Ozer, D El-Gamal, B Powell, ZA Hing, JS Blachly, B Harrington, ... Cancer discovery 8 (4), 458-477, 2018 | 120 | 2018 |
| Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia AM Dorrance, P Neviani, GJ Ferenchak, X Huang, D Nicolet, KS Maharry, ... Leukemia 29 (11), 2143-2153, 2015 | 120 | 2015 |
| miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing M Guerau-de-Arellano, H Alder, HG Ozer, A Lovett-Racke, MK Racke Journal of neuroimmunology 248 (1-2), 32-39, 2012 | 107 | 2012 |
| Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation K Orlovsky, A Kalinkovich, T Rozovskaia, E Shezen, T Itkin, H Alder, ... Proceedings of the National Academy of Sciences 108 (19), 7956-7961, 2011 | 101 | 2011 |
| Intensive care unit versus non–intensive care unit postoperative management of head and neck free flaps: comparative effectiveness and cost comparisons H Arshad, HG Ozer, A Thatcher, M Old, E Ozer, A Agarwal, H Jafari, ... Head & neck 36 (4), 536-539, 2014 | 84 | 2014 |
| Chromatin modification by SUMO-1 stimulates the promoters of translation machinery genes H Liu, J Zhang, GF Heine, M Arora, H Gulcin Ozer, R Onti-Srinivasan, ... Nucleic acids research 40 (20), 10172-10186, 2012 | 83 | 2012 |
| Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors AS Yilmaz, HG Ozer, JL Gillespie, DC Allain, MN Bernhardt, KC Furlan, ... Cancer 123 (7), 1184-1193, 2017 | 78 | 2017 |
| Using gene co-expression network analysis to predict biomarkers for chronic lymphocytic leukemia J Zhang, Y Xiang, L Ding, K Keen-Circle, TB Borlawsky, HG Ozer, R Jin, ... BMC bioinformatics 11, 1-9, 2010 | 71 | 2010 |
| Role of lysine methylation of NF-κB in differential gene regulation T Lu, M Yang, DB Huang, H Wei, GH Ozer, G Ghosh, GR Stark Proceedings of the National Academy of Sciences 110 (33), 13510-13515, 2013 | 61 | 2013 |
| Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations F Lucas, K Larkin, CT Gregory, S Orwick, TJ Doong, A Lozanski, ... Blood, The Journal of the American Society of Hematology 135 (24), 2192-2195, 2020 | 51 | 2020 |
| The impact of surgery in the management of the head and neck carcinoma involving the carotid artery E Ozer, A Agrawal, HG Ozer, DE Schuller The Laryngoscope 118 (10), 1771-1774, 2008 | 43 | 2008 |
| Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia JS Walker, ZA Hing, B Harrington, J Baumhardt, HG Ozer, A Lehman, ... Journal of hematology & oncology 14, 1-21, 2021 | 41 | 2021 |
| Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma V Karkhanis, L Alinari, HG Ozer, J Chung, X Zhang, S Sif, RA Baiocchi Journal of Biological Chemistry 295 (5), 1165-1180, 2020 | 39 | 2020 |
